British Journal of Haematology

Papers to be published in forthcoming issues
pp. x-x(1)

Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
pp. 251-251(1)

Retinopathy of anaemia in T-cell lymphoma
pp. 252-252(1)

Proteasome inhibition as novel treatment strategy in leukaemia
pp. 253-262(10)
Authors: Vink, J.; Cloos, J.; Kaspers, G. J. L.

Natural killer T cells and haemopoiesis
pp. 263-272(10)
Authors: Karadimitris, Anastasios; Patterson, Scott; Spanoudakis, Emmanouil

Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
pp. 273-282(10)
Authors: Goulden, Nick; Virgo, Paul; Grimwade, David

Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
pp. 283-293(11)
Authors: Cillessen, Saskia A.G.M.; Meijer, Chris J.L.M.; Ossenkoppele, Gert J.; Castricum, Kitty C.M.; Westra, August H.; Niesten, Petra; Muris, Jettie J.F.; Nijdam, Hoite F.; van der Hem, Klaas G.; Flens, Marcel; Hooijberg, Erik; Oudejans, Joost J.

Diagnosis of Burkitt lymphoma in due time: a practical approach
pp. 294-301(8)
Authors: Cogliatti, Sergio B.; Novak, Urban; Henz, Samuel; Schmid, Ulrico; Möller, Peter; Barth, Thomas F. E.

Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance
pp. 302-306(5)
Authors: Georgiou, Georgios; Karali, Vasiliki; Zouvelou, Christina; Kyriakou, Elias; Dimou, Maria; Chrisochoou, Stamatis; Greka, Paraskevi; Dufexis, Dimitrios; Vervesou, Elisavet; Dimitriadou, Evaggelia; Efthymiou, Anna; Petrikkos, Loizos; Dima, Katerina; Lilakos, Konstantinos; Panayiotidis, Panayiotis

Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation
pp. 307-313(7)
Authors: Keuren, Jeffery F.W.; Magdeleyns, Elke J.P.; Govers-Riemslag, José W.P.; Lindhout, Theo; Curvers, Joyce

Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
pp. 314-319(6)
Authors: Allen, Geoffrey A.; Hoffman, Maureane; Roberts, Harold R.; Monroe, Dougald M.

Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
pp. 320-322(3)
Authors: Bowles, Kristian M.; Bloxham, David M.; Perry, David J.; Baglin, Trevor P.

Platelet-dependent thrombography: a method for diagnostic laboratories
pp. 323-325(3)
Authors: Dargaud, Yesim; Luddington, Roger; Baglin, Trevor

Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
pp. 326-329(4)
Authors: Martin, Coralie; Bridger, Gary J.; Rankin, Sara M.

Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver
pp. 330-332(3)
Authors: Kunisaki, Shaun M.; Azpurua, Humberto; Fuchs, Julie R.; Graves, Sara C.; Zurakowski, David; Fauza, Dario O.

Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial
pp. 333-339(7)
Authors: Kwiatkowski, Janet L.; Granger, Suzanne; Brambilla, Donald J.; Brown, R. Clark; Miller, Scott T.; Adams, Robert J.

Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease in older adults
pp. 340-340(1)

Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults - response to Bain
pp. 340-341(2)

Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: correlation with clinical behaviour
pp. 341-343(3)

Incidence of invasive fungal infection in adult haematological malignancy: a prospective validation of a risk stratification scheme
pp. 343-345(3)

Intravenous immunoglobulin (IVIG)-mediated neutralisation of C5a: a direct mechanism of IVIG in the maintenance of a high FcγRIIB to FcγRIII expression ratio on macrophages
pp. 345-347(3)

Lymphocyte immunophenotype of circulating angioimmunoblastic T-cell lymphoma cells
pp. 347-348(2)

Does low-dose aspirin have antineoplastic effects in multiple myeloma?
pp. 349-350(2)

Erratum
pp. 351-351(1)

Novo Nordisk Haemophilia Foundation website
pp. 352-352(1)

MRCPath haemostasis training and update: University College London, London, UK 4-8 September 2006
pp. 353-353(1)